Cancer Communications is an open access oncology journal providing a platform for collaboration on basic, clinical, and translational cancer research.

Editors: Xu, Rui-Ha ; Publisher: Wiley ; 2023 Journal Impact Factor: 20.1 (Journal Citation Report, Axtarish of Science Group) ; ISSN: 2523-3548.

As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.

2023-24, 20.1 ; 2022, NA ; 2021, NA ...

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research.

Cancer Communications Key Metrics ; CiteScore. 14.3 ; Impact Factor. 15 - 20 ; SNIP. 2.72 ; Time to Publish. time-to-publish View Chart. 6. Mo.

3 сент. 2024 г. · Impact IF 2023 of Cancer Communications is 12.39. If the same upward trend persists, Impact IF may rise in 2024 as well.

5-year Impact Factor: 16.7, Best ranking: ONCOLOGY (Q1) ―, Percentage rank: 95.7%, Open Access Support: Hybrid and Open Access Support, Country: PEOPLES R ...

Cancer Communications is no longer published by BMC. The journal is continuing in cooperation with a new publisher as of 1 January 2020.

Journal metrics. 20.1 (2023). Journal Impact Factor™. 6%. Acceptance rate. 25.5 (2023). CiteScore™. 8 days. Submission to first decision. $2,800 / £2,100 / € ...